SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) — Neomorph, Inc., a biotechnology company pioneering molecular glue degraders to address previously undruggable proteins, today announced the first patient ...

Balancing the number of agents with fluctuating demand is an issue contact center business leaders know all too well. More often than not, you’re paying for idle agents during a lull, or your team is ...

Abstract: In the realm of AI-enhanced programming education, there is growing interest in using such tools to help students understand good coding principles. This study investigates the impact of ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, will present a total of 14 abstracts with its research collaborators from multiple studies ...

MIAMI, FL, Dec. 02, 2025 (GLOBE NEWSWIRE) -- NextNRG (NASDAQ: NXXT) a pioneer in AI-driven energy innovation that is transforming how energy is produced, managed, and delivered, has partnered with ...

Students doing certain degrees may no longer receive the same amount of reimbursement for their studies now that the Department of Education is implementing various measures from President Donald ...

Even before large pieces of the federal government shut down in October 2025, the Supplemental Nutrition Assistance Program, or SNAP – sometimes called the food stamp program – was in for some big ...

Forbes contributors publish independent expert analyses and insights. Mary Josephs is an expert in business ownership transitions. How can we create opportunities for more workers to enjoy the ...

Up until Monday morning, the entire market assumed that when Broadcom Inc. (AVGO) announced on the Q3 '25 earnings call, “We now have the benefit of an additional fourth significant customer...fourth ...

This post as been updated to correct the planned procurement cost for the MQ-25A program. WASHINGTON, D.C. — Aircraft carriers will remain key to projecting American power long into the future, as the ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved Hernexeos for adults with unresectable or metastatic HER2-mutant NSCLC. It received accelerated ...